| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shahram Zarrabian, Shole Jamali, Soheila Fazli-Tabaei, Abbas Haghparas. The cross-talk between dopaminergic and nitric oxide systems in the medial septal nucleus, and their distinct effects on anxiety-like behaviors in male rats. Journal of psychiatric research. vol 141. 2021-08-25. PMID:34198193. |
in this study, we investigated the possible interaction between the dopaminergic and nitric oxide (no) neurotransmitter systems in the medial septal nucleus and their roles in anxiety-like behaviors using elevated plus-maze (epm) test in male rats. |
2021-08-25 |
2023-08-13 |
rat |
| Alice Powell, Catriona Ireland, Simon J G Lewi. Visual Hallucinations and the Role of Medications in Parkinson's Disease: Triggers, Pathophysiology, and Management. The Journal of neuropsychiatry and clinical neurosciences. vol 32. issue 4. 2021-08-16. PMID:32374649. |
while dopaminergic medications have long been associated with pd psychosis, a clear causal link has not been established, and other neurotransmitter systems, particularly noradrenaline, serotonin, and acetylcholine, are implicated and important. |
2021-08-16 |
2023-08-13 |
Not clear |
| Lisa M Smits, Stefano Magni, Kaoru Kinugawa, Kamil Grzyb, Joachim Luginbühl, Sonia Sabate-Soler, Silvia Bolognin, Jay W Shin, Eiichiro Mori, Alexander Skupin, Jens C Schwambor. Single-cell transcriptomics reveals multiple neuronal cell types in human midbrain-specific organoids. Cell and tissue research. vol 382. issue 3. 2021-08-10. PMID:32737576. |
human midbrain organoids (hmos) have been described to contain midbrain-specific dopaminergic neurons that release the neurotransmitter dopamine. |
2021-08-10 |
2023-08-13 |
human |
| Renáta Androvičová, James G Pfaus, Saak V Ovsepia. Estrogen pendulum in schizophrenia and Alzheimer's disease: Review of therapeutic benefits and outstanding questions. Neuroscience letters. vol 759. 2021-08-06. PMID:34116197. |
we discuss specific effects of estrogen deficit on neurotransmitter systems such as cholinergic, dopaminergic, serotoninergic, and glutamatergic. |
2021-08-06 |
2023-08-13 |
Not clear |
| Yadan Zhao, Zichen Zhang, Siru Qin, Wen Fan, Wei Li, Jingyi Liu, Songtao Wang, Zhifang Xu, Meidan Zha. Acupuncture for Parkinson's Disease: Efficacy Evaluation and Mechanisms in the Dopaminergic Neural Circuit. Neural plasticity. vol 2021. 2021-07-29. PMID:34221005. |
it has also been found that acupuncture can protect dopaminergic neurons from degeneration via antioxidative stress, anti-inflammatory, and antiapoptotic pathways as well as modulating the neurotransmitter balance in the basal ganglia circuit. |
2021-07-29 |
2023-08-13 |
Not clear |
| Efthalia Angelopoulou, Yam N Paudel, Christina Piperi, Awanish Mishr. Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities. Journal of biochemical and molecular toxicology. vol 35. issue 4. 2021-07-27. PMID:33491302. |
in vivo evidence has demonstrated that oral administration of cinnamon powder and sodium benzoate may protect against dopaminergic cell death, striatal neurotransmitter dysregulation, and motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse models of pd. |
2021-07-27 |
2023-08-13 |
mouse |
| Mathis Hildonen, Amanda M Levy, Christina Dahl, Victoria A Bjerregaard, Lisbeth Birk Møller, Per Guldberg, Nanette M Debes, Zeynep Tüme. Elevated Expression of Genes. vol 12. issue 1. 2021-07-21. PMID:33445578. |
several neurotransmitter systems have been implicated in disease pathogenesis, and amongst these, the dopaminergic and the serotonergic pathways are the most widely studied. |
2021-07-21 |
2023-08-13 |
Not clear |
| Mutsuo Nuriya, Yosuke Ashikari, Takanori Iino, Takuya Asai, Jingwen Shou, Keiko Karasawa, Kaho Nakamura, Yasuyuki Ozeki, Yukari Fujimoto, Masato Yasu. Alkyne-Tagged Dopamines as Versatile Analogue Probes for Dopaminergic System Analysis. Analytical chemistry. vol 93. issue 27. 2021-07-21. PMID:34210142. |
however, the lack of probes that mimic dopamine in living tissues, owing to the neurotransmitter's small size, has hampered analysis of the dopaminergic system. |
2021-07-21 |
2023-08-13 |
Not clear |
| Yanyun Sun, Xiao-Jun Lu, Xinghui Fu, Ye Zhang, Yan Zhan, Jiabing Liu, Lingxia Zhao, Chun-Lin Xi. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease. Molecular and cellular biochemistry. vol 476. issue 2. 2021-07-19. PMID:33070275. |
parkinson's disease (pd) is a disorder characterized by a progressive loss of the dopaminergic neurons in the substantia nigra and a depletion of the neurotransmitter dopamine in the striatum. |
2021-07-19 |
2023-08-13 |
rat |
| Yosef Ron, Hedva Lerman, Einat Even-Sapi. [METABOLIC AND DOPAMINERGIC BRAIN FUNCTIONAL IMAGING IN DEMENTIA WITH LEWY BODIES]. Harefuah. vol 160. issue 7. 2021-07-16. PMID:34263568. |
cortical metabolism was obtained by pet with labeled glucose (fdg) and the dopaminergic activity by labeled precursor (f-dopa) of the neurotransmitter dopamine. |
2021-07-16 |
2023-08-13 |
Not clear |
| Juergen Dukart, Stefan Holiga, Michael Rullmann, Rupert Lanzenberger, Peter C T Hawkins, Mitul A Mehta, Swen Hesse, Henryk Barthel, Osama Sabri, Robert Jech, Simon B Eickhof. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Human brain mapping. vol 42. issue 3. 2021-07-14. PMID:33079453. |
based on this approach, we introduce a toolbox (juspace) allowing for cross-modal correlation of mri-based measures with nuclear imaging derived estimates covering various neurotransmitter systems including dopaminergic, serotonergic, noradrenergic, and gabaergic (gamma-aminobutric acid) neurotransmission. |
2021-07-14 |
2023-08-13 |
Not clear |
| Emily E Noble, Christine A Olson, Elizabeth Davis, Linda Tsan, Yen-Wei Chen, Ruth Schade, Clarissa Liu, Andrea Suarez, Roshonda B Jones, Claire de La Serre, Xia Yang, Elaine Y Hsiao, Scott E Kanosk. Gut microbial taxa elevated by dietary sugar disrupt memory function. Translational psychiatry. vol 11. issue 1. 2021-06-28. PMID:33790226. |
hippocampus transcriptome analyses revealed that early life sugar consumption altered gene expression in intracellular kinase and synaptic neurotransmitter signaling pathways, whereas parabacteroides microbial enrichment altered gene expression in pathways associated with metabolic function, neurodegenerative disease, and dopaminergic signaling. |
2021-06-28 |
2023-08-13 |
rat |
| Nabeel Ali, Amna Syeda, Tenzin Topgyal, Naseem Gaur, Asimul Isla. Parkinson's disease: A current perspectives on Parkinson's disease and key bioactive natural compounds as future potential drug candidates. Current drug targets. 2021-06-24. PMID:34165406. |
the hallmark of pd includes dopamine deficiency (neurotransmitter imbalance) due to the gradual loss of dopaminergic nerves in the substantia nigra in the midbrain. |
2021-06-24 |
2023-08-13 |
Not clear |
| Kirsten R Müller-Vahl, Laura Bindila, Beat Lutz, Frank Musshoff, Thomas Skripuletz, Charlotte Baumgaertel, Kurt-Wolfram Süh. Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 45. issue 8. 2021-06-23. PMID:32272483. |
it can be speculated that elevated endocannabinoid levels either represent secondary changes in order to compensate for alterations in other neurotransmitter systems such as the dopaminergic system, are simply an epiphenomenon or, alternatively, represent the primary cause of ts. |
2021-06-23 |
2023-08-13 |
Not clear |
| Mohammad Shimia, Arad Iranmehr, Amir Valizadeh, Farhad Mirzaei, Mohamad Namvar, Ebrahim Rafiei, Ahsan Rahimi, Aida Khadivi, Kamkar Aeinfa. A placebo-controlled randomized clinical trial of amantadine hydrochloride for evaluating the functional improvement of patients following severe acute traumatic brain injury. Journal of neurosurgical sciences. 2021-06-11. PMID:34114429. |
considering the known derangements in the dopaminergic neurotransmitter systems following traumatic brain injury (tbi), dopamine agonists are used as a pharmacologic option. |
2021-06-11 |
2023-08-13 |
Not clear |
| Miguel Perez de la Mora, Carlos Hernandez-Mondragon, Minerva Crespo-Ramirez, José Rejon-Orantes, Dasiel O Borroto-Escuela, Kjell Fux. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia. Neuroscience. vol 439. 2021-05-14. PMID:31349007. |
to accomplish this task dopaminergic neurons keep mutual modulating interactions with neurons of other neurotransmitter systems, including allosteric receptor-receptor interactions in heteroreceptor complexes. |
2021-05-14 |
2023-08-13 |
Not clear |
| Muhammed Khairujjaman Mazumder, Anupom Borah, Shuvasish Choudhur. Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalities. Medical hypotheses. vol 137. 2021-05-14. PMID:31954292. |
parkinson's disease (pd), a progressive neurodegenerative motor disorder, is caused due to the loss of dopaminergic neurons in the substantia nigra pars compacta region of mid-brain and the resultant depletion of the levels of the neurotransmitter dopamine. |
2021-05-14 |
2023-08-13 |
Not clear |
| Srijan Acharya, Kyeong-Man Ki. Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease. International journal of molecular sciences. vol 22. issue 9. 2021-05-13. PMID:33919025. |
dopaminergic (daergic) and cholinergic neurotransmitter system regulate various brain functions that include cognition, movement, emotion, etc. |
2021-05-13 |
2023-08-13 |
Not clear |
| Delaram Eslimi Esfahani, Mohammad Reza Zarrindas. Cholestasis and behavioral disorders. Gastroenterology and hepatology from bed to bench. vol 14. issue 2. 2021-05-13. PMID:33968336. |
it has been reported that after he, all classical neurotransmitter systems such as opioidergic, dopaminergic, cholinergic, gabaergic, adrenergic, serotonergic, and glutamatergic systems can be altered. |
2021-05-13 |
2023-08-13 |
Not clear |
| Andrea Fabbrini, Andrea Guerr. Pathophysiological Mechanisms and Experimental Pharmacotherapy for L-Dopa-Induced Dyskinesia. Journal of experimental pharmacology. vol 13. 2021-05-08. PMID:33953618. |
recent advances in the understanding of the pathophysiological mechanisms underlying lid suggest that abnormalities in multiple neurotransmitter systems, in addition to dopaminergic nigrostriatal denervation and altered dopamine release and reuptake dynamics at the synaptic level, are involved in lid development. |
2021-05-08 |
2023-08-13 |
Not clear |